A prospective study of serum lipids and the risk of diabetic retinopathy in type 1 diabetes

Shehla A. Khan; Tamar Ratiani; Nabeela Tazeen; Mussab A. Elhussein; Abhijeeth R. Toddi

doi:10.18203/issn.2454-2156.IntJSciRep20253764

Authors

Shehla A. Khan Bharati Vidyapeeth deemed University Medical College, Pune, Maharashtra, India
Tamar Ratiani David Tvildiani Medical University, Tbilisi, Georgia
Nabeela Tazeen Dr. V. R. K. Women's Medical College, Telangana, India
Mussab A. Elhussein Shendi University, Sudan
Abhijeeth R. Toddi Mediciti Institute of Medical Sciences, Telangana, India

DOI:

https://doi.org/10.18203/issn.2454-2156.IntJSciRep20253764

Keywords:

Diabetic retinopathy, Type 1 diabetes, Dyslipidemia

Abstract

Background: Diabetic retinopathy (DR) remains a leading cause of vision loss among individuals with type 1 diabetes, yet factors beyond hyperglycemia that contribute to its onset and progression are not fully understood. Dyslipidemia has been proposed as a modifiable risk factor, but evidence has been inconsistent

Methods: This prospective cohort study investigated the relationship between serum lipid levels and the risk of incident and progressive DR in 1,360 participants with type 1 diabetes, aged 14–38 years, followed for a mean of 6.2 years. Participants were stratified into primary prevention and secondary intervention groups and underwent annual fasting lipid measurements and standardized retinal photography, with outcomes graded according to the early treatment diabetic retinopathy study (ETDRS) scale.

Results: During follow-up, 312 new cases of DR, 286 cases of DR progression, and 94 cases of proliferative DR were identified. Higher LDL cholesterol and elevated total-to-HDL cholesterol ratio were significantly associated with incident DR (HR 2.68 and 3.05, respectively, highest vs. lowest quintile), while triglycerides and total-to-HDL cholesterol ratio predicted disease progression (HR 2.12 and 1.95, respectively). Associations with proliferative DR were attenuated after adjustment for glycemic control. HDL cholesterol showed no independent effect.

Conclusions: These findings suggest that lipid abnormalities contribute primarily to the early development and progression of DR rather than proliferative disease. Given that dyslipidemia is a modifiable risk factor, early identification and treatment may reduce the burden of vision loss in type 1 diabetes. Lipid management, alongside strict glycemic control, should be considered in preventive ophthalmic care.

Metrics

Metrics Loading ...

References

Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227-39. DOI: https://doi.org/10.1056/NEJMra1005073

Klein BE, Howard KP, Klein R. Relationships of serum total cholesterol (total-C) and high density lipoprotein cholesterol (HDLC) with risk of proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME) in persons with long term type 1 diabetes (T1D): the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Invest Ophthalmol Vis Sci. 2014;55:5350. DOI: https://doi.org/10.1001/jamaophthalmol.2014.5108

Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII: the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115(11):1859-68. DOI: https://doi.org/10.1016/j.ophtha.2008.08.023

Klein BE, Klein R, McBride PE, Cruickshanks KJ, Palta M, Knudtson MD, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med. 2004;164(17):1917-24. DOI: https://doi.org/10.1001/archinte.164.17.1917

Chew EY, Klein ML, Ferris FL III, Remaley NA, Murphy RP, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol. 1996;114(9):1079-84. DOI: https://doi.org/10.1001/archopht.1996.01100140281004

Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes. 2004;53(11):2883-92. DOI: https://doi.org/10.2337/diabetes.53.11.2883

Mann DM, Woodward M, Ye F, Krousel-Wood M, Muntner P. Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. Arch Intern Med. 2009;169(18):1718-20. DOI: https://doi.org/10.1001/archinternmed.2009.296

Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in U.S. adults? Diabetes Care. 2008;31(1):81-6. DOI: https://doi.org/10.2337/dc07-1572

Klein R, Klein BE. Are individuals with diabetes seeing better? A long-term epidemiological perspective. Diabetes. 2010;59(8):1853-60. DOI: https://doi.org/10.2337/db09-1904

Romero P, Salvat M, Fernández J, Baget M, Martinez I. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients. J Diabetes Complications. 2007;21(2):93-100. DOI: https://doi.org/10.1016/j.jdiacomp.2006.04.001

Simić I, Pećin I, Tedeschi-Reiner E, Zrinsćak O, Sućur N, Reiner Z. Risk factors for microvascular atherosclerotic changes in patients with type 2 diabetes mellitus. Coll Antropol. 2013;37(3):783-7.

Cetin EN, Bulgu Y, Ozdemir S, Topsakal S, Akın F, Aybek H, et al. Association of serum lipid levels with diabetic retinopathy. Int J Ophthalmol. 2013;6(3):346-9.

Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C; American College of Cardiology; American Heart Association; National Heart, Lung and Blood Institute. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002;40(3):567-72. DOI: https://doi.org/10.1016/S0735-1097(02)02030-2